Armed Forces: HIV Infection

Ministry of Defence written question – answered at on 4 April 2022.

Alert me about debates like this

Photo of Luke Pollard Luke Pollard Shadow Minister (Defence)

To ask the Secretary of State for Defence, pursuant to the Answer of 15 March 2022 to Question 136649 on Armed Forces: HIV infection, for what reason the updated policy cannot be published before August 2022.

Photo of Luke Pollard Luke Pollard Shadow Minister (Defence)

To ask the Secretary of State for Defence, pursuant to the Answer of 15 March 2022 to Question 136649 on Armed Forces: HIV infection, what the reasons are for the current ban on PrEP use in Aircrew and Air Traffic Controllers.

Photo of Leo Docherty Leo Docherty Parliamentary Under-Secretary of State (jointly with the Ministry of Defence)

Seemingly innocuous medication side effects can have serious safety implications in the military aviation context. Consequently, approving medication use in aviation is a rigorous, evidence-based process involving a number of pharmacists, medical and aviation experts. The process ensures benchmarking with other military organisations and civilian counterparts.

This extensive process is currently underway to approve PrEP and it is expected to result in revised policy being published in August 2022. The aspiration is to publish sooner if possible and the process is currently being advanced to achieve this.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.